2Q FY 2026 Earnings Supplemental Slides Safe Harbor Statements we make in this presentation may include statements which are not historical facts and are considered forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, which are usually identified by the use of words such as "anticipates," "believes," "estimates," "expects," "intends," "may," "plans," "possible," "projects," "outlook," "seeks," "should," "will," and variations of such words or similar expressions, inclu ...

Financial Performance - Total revenue reached $2.5 billion, a 7% increase[2] - Diluted EPS was $3.10, a 2% decrease[2] - Total comparable sales increased by 1%[2] Segment Performance - Women's apparel revenue increased by 5%[7] - Men's apparel revenue increased by 6%[7] - Accessories and other revenue increased by 15%[7] - Store revenue increased by 3%[8] - Digital revenue increased by 9%[8] Market Performance - Americas revenue increased by 1%[9] - International revenue increased by 22%[9] Company Strategy - The company ended Q2 with 784 company-operated stores globally[9]

Company Overview - ICU Medical's 2024 revenues reached $2.35 billion[8] - The company's revenue mix includes 44% from consumables and 28% from systems pre-JV, which shifts to 52% and 33% post-JV respectively[6] - Vital Care accounts for 28% of revenue pre-JV and 16% post-JV[7] - Geographically, 64% of revenue comes from the US & Canada, and 36% from OUS post-JV[11] - Single-use consumables make up 88% of revenue, while hardware accounts for 12% post-JV[11] Financial Highlights - The company's diluted equity value is $3.2 billion, with a net debt of $1.0 billion, resulting in an enterprise value of $4.2 billion[11] Growth and Strategy - The industry is experiencing pump replacement cycle acceleration due to distinct circumstances[14] - The company is focused on improving its quality system and FDA warning letter remediation[37] - The company aims to achieve gross margin expansion, targeting 42-43% in the near-med term and 45% in the longer term[34] - The company is working towards a fully stable supply chain, production, and distribution network[37] - The company is focused on contract renewals of a significant portion of L-ICU US sales in late 2024[37]

Financial Performance - Braze's quarterly revenue run rate is $720 million[3] - Q2 2026 revenue reached $1801 million, a 238% year-over-year increase and an 111% sequential growth[10, 14] - The GAAP gross margin was 677%, while the non-GAAP gross margin was 693%[10, 16] - The dollar-based net retention rate was 108%[4, 10, 18] - GAAP operating loss was $388 million, compared to a $280 million loss in the prior year quarter, while non-GAAP operating income was $60 million, compared to $42 million in the prior year quarter[10] - Net cash provided by operating activities was $70 million, compared to $310 million in the prior year quarter[10] - Free cash flow was $35 million, compared to $72 million in the prior year quarter[10, 23] Customer Growth - The customer base increased to 2,422 as of July 31, 2025, from 2,163 in the prior year quarter, representing a 12% year-over-year growth[4, 10, 20] Guidance - Q3 2026 revenue is projected to be between $1835 million and $1845 million, and full-year 2026 revenue is expected to be between $7170 million and $7200 million[29]

Financial Performance & Strategy - FY25 revenues reached $1,137.8 million[69] - The company achieved a 5-year revenue CAGR of 34%[17,69] - Adjusted EPS 5-year CAGR was +88%[17] - Organic revenue 5-year CAGR was +24%[17,69] - Adjusted FY25 Free Cash Flow reached $243291 thousand[49,75] - Net leverage was significantly reduced to 24x[49] - The company anticipates approximately $1 billion total Free Cash Flow over the next four years[51] E-commerce & International Expansion - E-commerce as a percentage of net sales has increased +4x from approximately 4% in FY19 to approximately 16% in FY25[33] - International revenue accounts for approximately 16% of Prestige Net Sales in FY25[45] FY26 Outlook - Expected revenue for FY26 is projected to be between $1,100 to $1,115 million[59] - Projected FY26 Non-GAAP Free Cash Flow is $245 million[59,77]

Financial Performance - The Toro Company's Q3 2025 net sales were $1,131.3 million, a decrease of 2.2% compared to $1,156.9 million in Q3 2024[25] - Adjusted diluted EPS for Q3 2025 was $1.24, a 5.1% increase from $1.18 in Q3 2024[25] - The company repurchased $90 million of its common stock during Q3 2025[6] - The company updated its full-year fiscal 2025 adjusted diluted EPS guidance to approximately $4.15[6] Segment Results - Professional segment net sales increased by 5.7%, from $880.9 million in Q3 2024 to $930.8 million in Q3 2025[27] - Professional segment earnings margin increased by 250 bps, from 18.8% in Q3 2024 to 21.3% in Q3 2025[27] - Residential segment net sales decreased by 27.9%, from $267.5 million in Q3 2024 to $192.8 million in Q3 2025[30] - Residential segment earnings margin decreased by 1030 bps, from 12.2% in Q3 2024 to 1.9% in Q3 2025[30] Cost Savings and Efficiency - The company's AMP initiative is expected to deliver at least $100 million in incremental annualized cost savings by fiscal 2027[22] - Approximately $4 million of run-rate savings were achieved in Q3 2025 through the AMP initiative[24] Tariff Mitigation - The company estimates fiscal 2025 tariff headwinds to be approximately $70 million, down from a prior estimate of approximately $90 million[7] - The company is on track to mitigate 100% of tariff headwinds for full-year 2025[9]

Financial Performance - Q2 FY26 - Revenue decreased from $1.818 billion in FY25 to $1.769 billion in FY26[13], a decrease of approximately 2.7% - Adjusted EBITDA increased from $170 million in FY25 to $185 million in FY26[14], representing an increase of approximately 8.8% - Adjusted Diluted EPS increased significantly from $2.05 in FY25 to $3.63 in FY26[15] - Free Cash Flow decreased from $241 million in FY25 to $150 million in FY26[16] Fiscal Year 2026 Guidance - Revenue guidance is revised downwards to $7.250 billion - $7.325 billion, compared to the prior guidance of $7.60 billion - $7.75 billion[19] - Organic growth is expected to be approximately -2% to -3%[19] - Adjusted EBITDA is projected to be $680 million - $690 million, with a margin of 9.3% - 9.5%[19] - Adjusted Diluted EPS is expected to be $9.40 - $9.60[19] - Free Cash Flow is projected to be greater than $550 million[19] Business Development - The company is navigating near-term revenue pressure due to a challenging environment for on-contract growth and new business award delays [5] - The company is implementing cost efficiency initiatives, including artificial intelligence, to drive greater efficiency and leverage investments [5]

General Information - Hyatt recently opened Park Hyatt Johannesburg in July 2025[1] - The presentation contains forward-looking statements subject to risks and uncertainties[2] Forward-Looking Statements Disclaimer - Actual results may differ materially from those expressed or implied due to various factors, including economic conditions, supply chain constraints, and geopolitical events[2] - The company is not obligated to update forward-looking statements[2]

First Quarter 2026 Earnings Review NON-GAAP FINANCIAL MEASURES Wiley provides non-GAAP financial measures and performance results such as: Management believes non-GAAP financial measures, which exclude the impact of restructuring charges and credits and certain other items, and the impact of divestitures and acquisitions provide a useful comparable basis to analyze operating results and earnings. See the reconciliations of non-GAAP financial measures and explanations of the uses of non-GAAP measures in the ...

Financial Performance - Q2 2025 - Sales decreased to $659 million, a 3.6% decrease compared to $683 million in 2Q24[19, 16] - Adjusted Earnings Per Share (EPS) decreased to $0.35, compared to $0.85 in 2Q24[19, 16] - Gross margin was 43.4%, down 210 bps compared to 2Q24[19] - Inventory increased by 5% compared to 2Q24[19] - Adjusted EBITDA was $163 million[19] Segment Performance - **Famous Footwear:** Sales were $400 million, down 4.9% year-over-year, with comparable sales down 3.4%[26] Gross margin was 43.7%, down 130 bps year-over-year[26] - **Brand Portfolio:** Sales were $276 million, down 3.5% compared to 2Q24, including a $10 million impact from tariffs[21] Gross margin was 40.3%, down 240 bps compared to 2Q24[22] Outlook - Famous Footwear expects comparable sales to be up 1% in August, down low-single digits in September and October[30] - The Brand Portfolio expects Q3 gross margin to be down similar to Q2, with Q4 trends improving as mitigation strategies benefit[30] Strategic Initiatives - The company achieved $15 million in annualized, structural savings[14] - The company is partnering with a consulting firm to explore additional structural cost savings across the portfolio[30]